Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian M Duchesne

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|August 12, 2016
Timing of androgen-deprivation therapy for prostate cancer: still a long way to go - Authors' replyGillian M Duchesne
The Lancet. Oncology|February 17, 2019
Effective and well tolerated: where do these drugs fit now?Gillian M Duchesne
BJU International|July 23, 2014
The 'Timing of Androgen-Deprivation therapy in incurable prostate cancer' protocol (TOAD)--where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trialGillian M Duchesne, Henry H Woo
The Lancet. Oncology|December 7, 2017
Timing of androgen-deprivation therapy in prostate cancer - Author's replyGillian M Duchesne, Henry H Woo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
How early is early: androgen deprivation for prostate-specific antigen relapse in prostate cancerGillian M Duchesne, Rodney Syme, Deborah Howell
International Journal of Radiation Oncology, Biology, Physics|September 9, 2014
Around the globe--Radiation oncology in AustraliaGillian M Duchesne, Sandra L Turner, Sonja Cronje
International Journal of Radiation Oncology, Biology, Physics|April 4, 2015
In reply to JenkinsGillian M Duchesne, Sonja Cronje, Sandra L Turner
Australasian Radiology|November 28, 2002
Dose distribution and morbidity after high dose rate brachytherapy for prostate cancer: influence of V150 and V200 parametersGillian M Duchesne, Ram Das, Warren Toye, et al.
Journal of Medical Imaging and Radiation Oncology|March 9, 2011
Imaging, radiation oncology and randomised trials: time for a change?Gillian M Duchesne, Shih-Chang Wang, Rodney J Hicks
Acta Oncologica (Stockholm, Sweden)|August 12, 2004
Trends in the use of androgen deprivation in prostate cancerEeva K Salminen, Jan-Erik Wickström, Tero Vahlberg, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|August 12, 2016
Timing of androgen-deprivation therapy for prostate cancer: still a long way to go - Authors' replyGillian M Duchesne
The Lancet. Oncology|February 17, 2019
Effective and well tolerated: where do these drugs fit now?Gillian M Duchesne
BJU International|July 23, 2014
The 'Timing of Androgen-Deprivation therapy in incurable prostate cancer' protocol (TOAD)--where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trialGillian M Duchesne, Henry H Woo
The Lancet. Oncology|December 7, 2017
Timing of androgen-deprivation therapy in prostate cancer - Author's replyGillian M Duchesne, Henry H Woo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
How early is early: androgen deprivation for prostate-specific antigen relapse in prostate cancerGillian M Duchesne, Rodney Syme, Deborah Howell
International Journal of Radiation Oncology, Biology, Physics|September 9, 2014
Around the globe--Radiation oncology in AustraliaGillian M Duchesne, Sandra L Turner, Sonja Cronje
International Journal of Radiation Oncology, Biology, Physics|April 4, 2015
In reply to JenkinsGillian M Duchesne, Sonja Cronje, Sandra L Turner
Australasian Radiology|November 28, 2002
Dose distribution and morbidity after high dose rate brachytherapy for prostate cancer: influence of V150 and V200 parametersGillian M Duchesne, Ram Das, Warren Toye, et al.
Journal of Medical Imaging and Radiation Oncology|March 9, 2011
Imaging, radiation oncology and randomised trials: time for a change?Gillian M Duchesne, Shih-Chang Wang, Rodney J Hicks
Acta Oncologica (Stockholm, Sweden)|August 12, 2004
Trends in the use of androgen deprivation in prostate cancerEeva K Salminen, Jan-Erik Wickström, Tero Vahlberg, et al.
Pageof 5